0001911051-22-000003.txt : 20220829
0001911051-22-000003.hdr.sgml : 20220829
20220829215710
ACCESSION NUMBER: 0001911051-22-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220825
FILED AS OF DATE: 20220829
DATE AS OF CHANGE: 20220829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fralick Celeste Rachelle
CENTRAL INDEX KEY: 0001911051
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34810
FILM NUMBER: 221212791
MAIL ADDRESS:
STREET 1: 2801 MESA ROAD
CITY: LUBBOCK
STATE: TX
ZIP: 79403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aspira Women's Health Inc.
CENTRAL INDEX KEY: 0000926617
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 330595156
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
BUSINESS PHONE: 512-519-0400
MAIL ADDRESS:
STREET 1: 12117 BEE CAVES ROAD BUILDING THREE
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78738
FORMER COMPANY:
FORMER CONFORMED NAME: VERMILLION, INC.
DATE OF NAME CHANGE: 20070824
FORMER COMPANY:
FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC
DATE OF NAME CHANGE: 20000316
FORMER COMPANY:
FORMER CONFORMED NAME: ABIOTIC SYSTEMS
DATE OF NAME CHANGE: 19950407
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-08-25
0
0000926617
Aspira Women's Health Inc.
AWH
0001911051
Fralick Celeste Rachelle
C/O ASPIRA WOMEN'S HEALTH INC.
12117 BEE CAVES RD, BLDG 3-100
AUSTIN
TX
78738
1
0
0
0
Common Stock
2022-08-25
4
P
0
6667
A
102945
D
Warrant (right to buy)
0.88
2022-08-25
4
P
0
6667
A
2022-08-25
2027-08-25
Common stock, par value $0.001
6667
6667
D
Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit.
Total reflects the adjustment of 3,393 shares of common stock previously reported as part of a restricted stock unit grant made on March 31, 2022.
/s/ Celeste Fralick
2022-08-29